BARCLAYS PLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2022$234,000
+875.0%
136,136
+288.7%
0.00%
Q1 2022$24,000
-95.7%
35,027
-93.1%
0.00%
Q4 2021$556,000
+251.9%
508,868
+486.2%
0.00%
Q3 2021$158,000
+97.5%
86,803
+188.8%
0.00%
Q2 2021$80,000
-87.7%
30,055
-83.4%
0.00%
Q1 2021$650,000
+261.1%
180,583
+152.5%
0.00%
Q4 2020$180,000
-26.5%
71,522
-26.6%
0.00%
Q3 2020$245,000
-37.7%
97,487
-18.6%
0.00%
Q2 2020$393,000
+148.7%
119,782
+84.9%
0.00%
Q1 2020$158,000
-82.4%
64,769
-66.0%
0.00%
Q4 2019$898,000
+19.6%
190,345
+8.6%
0.00%
Q3 2019$751,000
-55.1%
175,203
-38.9%
0.00%
-100.0%
Q2 2019$1,671,000
+134.4%
286,720
+54.9%
0.00%
Q1 2019$713,000
+369.1%
185,128
+127.0%
0.00%
Q4 2018$152,000
-66.7%
81,562
-43.0%
0.00%
Q3 2018$457,000
+331.1%
142,988
+307.7%
0.00%
Q2 2018$106,0000.0%35,070
+28.6%
0.00%
Q1 2018$106,000
-68.4%
27,264
-66.3%
0.00%
Q4 2017$335,000
-8.0%
80,932
+36.5%
0.00%
Q3 2017$364,000
+7180.0%
59,286
+8801.8%
0.00%
Q2 2017$5,000
-80.8%
666
-83.9%
0.00%
Q1 2017$26,000
-99.2%
4,139
-99.4%
0.00%
-100.0%
Q4 2016$3,450,000
+2329.6%
644,738
+2441.3%
0.00%
Q3 2016$142,000
+14100.0%
25,370
+25270.0%
0.00%
Q2 2016$1,000
-98.9%
100
-99.3%
0.00%
Q1 2016$94,000
+9300.0%
13,354
+8515.5%
0.00%
Q4 2015$1,000
-98.4%
155
-97.8%
0.00%
Q3 2015$63,000
-45.2%
6,996
-27.2%
0.00%
Q2 2015$115,000
-97.8%
9,604
-98.1%
0.00%
-100.0%
Q1 2015$5,130,000
+251.4%
513,024
+75.8%
0.01%
+500.0%
Q4 2014$1,460,000
+298.9%
291,822
+59.1%
0.00%
Q3 2014$366,000
-74.0%
183,375
-47.9%
0.00%
-100.0%
Q2 2014$1,407,000
-66.1%
351,666
-66.1%
0.00%
-80.0%
Q1 2014$4,149,000
-25.8%
1,036,887
-25.8%
0.01%
-16.7%
Q4 2013$5,590,000
+78.3%
1,397,194
+33.7%
0.01%
+50.0%
Q3 2013$3,135,000
+119.8%
1,045,096
+54.6%
0.00%
+100.0%
Q2 2013$1,426,000675,9670.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders